TRAF4 and osteoporosis: Taken together, our findings suggest that TRAF4 positively regulates the osteogenic process of MSCs both in vitro and in vivo, can be a promising target not only to improve the efficiency of MSC-based tissue engineering therapy for bone regeneration and repair but also to treat the pathogenesis of bone metabolism disorders, such as osteoporosis.